amlodipine has been researched along with Berger Disease in 3 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the present study was to compare the effects of losartan and amlodipine on proteinuria, as well as on serum and urine TGF-beta1 levels in IgA nephropathy patients with hypertension and proteinuria." | 9.10 | Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy. ( Choi, KH; Choi, S; Goo, YS; Ha, SK; Han, DS; Kang, SW; Lee, HY; Park, HC; Xu, ZG, 2003) |
| " The aim of the present study was to compare the effects of losartan and amlodipine on proteinuria, as well as on serum and urine TGF-beta1 levels in IgA nephropathy patients with hypertension and proteinuria." | 5.10 | Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy. ( Choi, KH; Choi, S; Goo, YS; Ha, SK; Han, DS; Kang, SW; Lee, HY; Park, HC; Xu, ZG, 2003) |
| "Forty-nine hypertensive IgA nephropathy (IgAN) patients (39 +/- 7 years old, serum creatinine 1." | 2.69 | Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up. ( Kanno, Y; Okada, H; Saruta, T; Suzuki, H, 2000) |
| "Patients with immunoglobulin A nephropathy administered ACE inhibitors showed significantly lower renal TGF-beta1 gene expression than patients not administered these medications (mean ratios of TGF-beta1/beta-actin, 4." | 1.31 | ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans. ( Kim, D; Kim, HS; Kim, SJ; Ma, KA; Shin, GT, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, HC | 1 |
| Xu, ZG | 1 |
| Choi, S | 1 |
| Goo, YS | 1 |
| Kang, SW | 1 |
| Choi, KH | 1 |
| Ha, SK | 1 |
| Lee, HY | 1 |
| Han, DS | 1 |
| Shin, GT | 1 |
| Kim, SJ | 1 |
| Ma, KA | 1 |
| Kim, HS | 1 |
| Kim, D | 1 |
| Kanno, Y | 1 |
| Okada, H | 1 |
| Saruta, T | 1 |
| Suzuki, H | 1 |
2 trials available for amlodipine and Berger Disease
| Article | Year |
|---|---|
Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Female; Glomerulonephritis, IGA; Humans; | 2003 |
Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; | 2000 |
1 other study available for amlodipine and Berger Disease
| Article | Year |
|---|---|
ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Block | 2000 |